Factors ID'd for outcome of percutaneous nephrolithotomy

July 3, 2012
Factors ID'd for outcome of percutaneous nephrolithotomy
Single-tract percutaneous nephrolithotomy is effective for clearing renal stones, with stone size, location, and prior shockwave lithotripsy identified as independent predictors of stone clearance, according to a study published in the July issue of Urology.

(HealthDay) -- Single-tract percutaneous nephrolithotomy (sPCNL) is effective for clearing renal stones, with stone size, location, and prior shockwave lithotripsy (SWL) identified as independent predictors of stone clearance, according to a study published in the July issue of Urology.

Khaled Shahrour, M.D., from the University of Toledo Medical Center in Ohio, and colleagues conducted a retrospective review of 351 cases of sPCNL performed by one of two endourologists at a single institution between January 2000 and March 2010. Analyses included preoperative patient and factors.

The researchers found that the stone-free rate (SFR) was 76 percent after either an initial procedure or a second-look nephroscopy. Lower SFR correlated with rising preoperative creatinine, , increasing stone , complete staghorn stone, presence of stones in the upper pole, and absence of prior SWL, in univariate analysis. In multivariate analysis, stone size, presence of stones in the upper pole, and prior SWL for the active burden remained independent predictors of SFR.

"The purpose of the study is to evaluate the preoperative factors that affect outcome of sPCNL, to aid urologists and patients in making the most appropriate decisions concerning the type of stone treatment," the authors write. "Further development of a predictive of stone clearance and complications is currently being performed"

Explore further: Study finds no correlation between primary kidney stone treatment and diabetes

More information: Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Study finds no correlation between primary kidney stone treatment and diabetes

October 21, 2011
A Mayo Clinic study finds no correlation between the use of shock waves to break up kidney stones and the long-term development of diabetes. The study was released Friday during a meeting of the North Central Section of the ...

Recommended for you

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Flu may be spread just by breathing, new study shows; coughing and sneezing not required

January 18, 2018
It is easier to spread the influenza virus (flu) than previously thought, according to a new University of Maryland-led study released today. People commonly believe that they can catch the flu by exposure to droplets from ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.